Why did ABT.SW stock fall in pre-market trading?

The pre-market drop reflects profit-taking, valuation re-rating, and headline risk about deals and sector flows. Thin Swiss-listed volume amplified the move, pushing the price to **CHF88.00** and testing support at **CHF85.00**.

What are the key valuation metrics for Abbott (ABT.SW)?

Abbott shows EPS **2.89**, PE **30.45**, market cap **CHF153.02B**, and free cash flow yield **3.73%**. These figures point to growth at a premium versus some peers, increasing sensitivity to negative news.

What is Meyka AI's short and medium forecast for ABT.SW?

Meyka AI's forecast model projects **CHF87.30** for one month and **CHF100.56** for one year. The one-year projection implies **+14.27%** upside from **CHF88.00**. Forecasts are model-based projections and not guarantees.

Where are logical support and resistance levels for trading ABT.SW?

Short-term support is near the year low **CHF85.00** and resistance near the 50-day average **CHF95.35**. Use stops and size positions to manage downside risk.

CH Stocks

Pre-market: ABT.SW Abbott Laboratories (SIX) -12.00% to CHF88.00: watch CHF85.00

ByHuzaifa Zahoor February 26, 2026

ABT.SW stock opens the Swiss pre-market sharply lower after a one-day fall of -12.00%, trading at CHF88.00 on the SIX. The drop follows market re-pricing after recent headlines and pushes Abbott Laboratories well below its 50-day average of CHF95.35. We focus on fundamentals, technical signals, and short-term catalysts to explain the move and identify where traders may find support near CHF85.00.